NCT02335892View on ClinicalTrials.gov

PROFILE - Evaluation of QoL and PRO Outcomes in Patients Taking Fingolimod

CompletedOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

November 11, 2014

Primary Completion Date

February 1, 2017

Study Completion Date

February 1, 2017

Conditions
Relapsing Remitting Multiple Sclerosis
Trial Locations (14)

TR1 3LJ

Novartis Investigative Site, Truro

SA6 6NL

Novartis Investigative Site, Swansea

RM7 0AG

Novartis Investigative Site, Romford

RG24 9NA

Novartis Investigative Site, Basingstoke

EH16 4SA

Novartis Investigative Site, Edinburgh

G51 4TF

Novartis Investigative Site, Glasgow

LE5 4PW

Novartis Investigative Site, Leicester

L9 7LT

Novartis Investigative Site, Liverpool

E1 1BB

Novartis Investigative Site, London

SW17 0QT

Novartis Investigative Site, London

W6 8RF

Novartis Investigative Site, London

WC1N 3BG

Novartis Investigative Site, London

NR4 7UY

Novartis Investigative Site, Norwich

NG5 1PB

Novartis Investigative Site, Nottingham

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY